Abraham (Abe) Ceesay

Abe Ceesay has a diverse and extensive work experience in the biopharmaceutical and healthcare industries. Abraham (Abe) currently serves as the Chief Executive Officer at Rapport Therapeutics since March 2023. Prior to this, they held the position of President at Cerevel Therapeutics from April 2021 to March 2023. Abraham (Abe) also served as the Chief Operating Officer at scPharmaceuticals from March 2016 to October 2018.

Abe has also actively participated in various board and committee roles. Abraham (Abe) was a Member of the Board of Trustees at the Museum of Science since June 2022, a Board Member at Camp Harbor View from December 2019 to October 2021, and a Board Member at Food For Free Committee, Inc. from December 2017 to April 2020.

In addition, Abe has held leadership positions in different companies. Abraham (Abe) was the Chairperson of the Board at Life Science Cares since October 2020, Head of Commercial: Sales, Marketing, and Operations at Keryx Biopharmaceuticals from February 2014 to March 2016, and Vice President of Marketing at Ironwood Pharmaceuticals from July 2010 to February 2014.

Abe also has experience as a Chief Executive Officer in the clinical stage biopharmaceutical company Tiburio Therapeutics, where they provided leadership from January 2019 to April 2021.

Abraham (Abe) Ceesay attended Ithaca College from 1996 to 2000, where they obtained a Bachelor of Science degree. The field of study for their bachelor's degree is not specified. At a later point in their education, Abe pursued an MBA degree at Suffolk University - Sawyer Business School. Their MBA degree was focused on Finance, General, however, the specific duration of their enrollment in this program is not provided.